Preclinical evaluation of antimicrobial nanodrugs. (2020)
- Record Type:
- Book
- Title:
- Preclinical evaluation of antimicrobial nanodrugs. (2020)
- Main Title:
- Preclinical evaluation of antimicrobial nanodrugs
- Further Information:
- Note: Juan Bueno.
- Other Names:
- Bueno, Juan
- Contents:
- Intro -- Dedication -- Preface -- Contents -- Chapter 1: Antimicrobial Screening: Foundations and Interpretation -- 1.1 Introduction -- 1.2 Antimicrobial Susceptibility Testing from Anti-infectives Research Until Clinical Use -- 1.3 Phenotypic Resistance Versus Genetic Resistance -- 1.4 Antimicrobial Susceptibility Testing and Virulence Factors -- 1.5 Biomarkers and Antimicrobial Testing -- 1.6 Integral Antimicrobial Susceptibility Testing -- 1.7 Biosensors in Antimicrobial Evaluation -- 1.8 Conclusions -- References Chapter 2: Antimicrobial Activity of Nanomaterials: From Selection to Application -- 2.1 Introduction -- 2.2 Antimicrobial Activity of Nanomaterials -- 2.3 Antimicrobial Models for Nanomaterials Evaluation -- 2.4 Implementation of Antimicrobial Methods for Nanomaterials Evaluation -- 2.5 Selection Criteria on the Basis of Biodegradability and Toxicity -- 2.6 Therapeutic Index in Nanomaterials -- 2.7 Conclusions -- References -- Chapter 3: Synergy and Antagonism: The Criteria of the Formulation -- 3.1 Introduction -- 3.2 Multi-target Antimicrobial Strategy 3.3 Antimicrobial Nanoformulations in Drug Delivery -- 3.4 Antimicrobial Nanotheranostics Trojan Horse -- 3.5 Cellomics of Synergism Under a Multi-target Strategy -- 3.6 Biofilm Penetration: Synergy and Strategy -- 3.7 Conclusions -- References -- Chapter 4: In Vitro Nanotoxicity: Toward the Development of Safe and Effective Treatments -- 4.1 Introduction -- 4.2 Nanomaterials in Interaction with Tissues -- 4.3Intro -- Dedication -- Preface -- Contents -- Chapter 1: Antimicrobial Screening: Foundations and Interpretation -- 1.1 Introduction -- 1.2 Antimicrobial Susceptibility Testing from Anti-infectives Research Until Clinical Use -- 1.3 Phenotypic Resistance Versus Genetic Resistance -- 1.4 Antimicrobial Susceptibility Testing and Virulence Factors -- 1.5 Biomarkers and Antimicrobial Testing -- 1.6 Integral Antimicrobial Susceptibility Testing -- 1.7 Biosensors in Antimicrobial Evaluation -- 1.8 Conclusions -- References Chapter 2: Antimicrobial Activity of Nanomaterials: From Selection to Application -- 2.1 Introduction -- 2.2 Antimicrobial Activity of Nanomaterials -- 2.3 Antimicrobial Models for Nanomaterials Evaluation -- 2.4 Implementation of Antimicrobial Methods for Nanomaterials Evaluation -- 2.5 Selection Criteria on the Basis of Biodegradability and Toxicity -- 2.6 Therapeutic Index in Nanomaterials -- 2.7 Conclusions -- References -- Chapter 3: Synergy and Antagonism: The Criteria of the Formulation -- 3.1 Introduction -- 3.2 Multi-target Antimicrobial Strategy 3.3 Antimicrobial Nanoformulations in Drug Delivery -- 3.4 Antimicrobial Nanotheranostics Trojan Horse -- 3.5 Cellomics of Synergism Under a Multi-target Strategy -- 3.6 Biofilm Penetration: Synergy and Strategy -- 3.7 Conclusions -- References -- Chapter 4: In Vitro Nanotoxicity: Toward the Development of Safe and Effective Treatments -- 4.1 Introduction -- 4.2 Nanomaterials in Interaction with Tissues -- 4.3 Toxic Dose 50 and Lethal Dose 50 in Nanotechnology -- 4.4 Drug Interactions and Adverse Events with Nanodrugs -- 4.5 Immunotoxicity: Immune Response Without Control 4.6 Genotoxicity, Epi-genotoxicity, and Carcinogenesis -- 4.7 Nanotoxicokinetics -- 4.8 Conclusions -- References -- Chapter 5: ADMETox: Bringing Nanotechnology Closer to Lipinski's Rule of Five -- 5.1 Introduction -- 5.2 ADMET Score -- 5.3 Absorption and Interaction with Biological Systems in Nanotechnology -- 5.4 Distribution: Specificity After Absorption -- 5.5 Metabolism: Nanomaterial Clearance -- 5.6 Nanopharmaceutical Excretion: The Risk of Gastrointestinal Disorders -- 5.7 Conclusions -- References Chapter 6: Antimicrobial Nanotechnology in Preventing the Transmission of Infectious Disease -- 6.1 Introduction -- 6.2 Nanomaterials in Antimicrobial Surfaces -- 6.3 Antibiofilm Activity of Antimicrobial Nanotechnology -- 6.4 Antiquorum Sensing: Avoid Dissemination by Preventing Communication -- 6.5 Nanomaterials and Surfactant Activity -- 6.6 Nano-Bio Interaction and Antimicrobial Effects -- 6.7 Nanotoxicological Models in Antimicrobial Coatings -- 6.8 Conclusions -- References -- Chapter 7: Nanotechnology in the Discovery of New Antimicrobial Drugs: Is a New Scientific Revolution Possible? … (more)
- Publisher Details:
- Cham : Springer
- Publication Date:
- 2020
- Extent:
- 1 online resource (125 p.)
- Subjects:
- 615.7/92
Anti-infective agents
Nanomedicine
Anti-infective agents
Nanomedicine
Electronic books
Electronic books - Languages:
- English
- ISBNs:
- 9783030438555
3030438554 - Related ISBNs:
- 9783030438548
3030438546 - Notes:
- Note: Includes bibliographical references and index.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.507776
- Ingest File:
- 03_084.xml